$PRPH
ProPhase Labs, Inc. Stock $prph

$prph Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000086827823000017 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$4.351M	$8.365M	$24.20M
YoY Change	-80.06%	-65.43%	155.49%
Cost Of Revenue	$7.407M	$6.038M	$12.23M
YoY Change	-29.72%	-50.62%	122.51%
Gross Profit	-$3.056M	$2.327M	$11.97M
YoY Change	-127.08%	-80.56%	201.06%
Gross Profit Margin	-70.24%	27.82%	49.48%
Selling, General & Admin	$8.022M	$8.250M	$7.512M
YoY Change	-37.04%	9.82%	26.51%
% of Gross Profit		354.53%	62.74%
Research & Development	$274.0K	$428.0K	$110.0K
YoY Change	-42.68%	289.09%	-47.12%
% of Gross Profit		18.39%	0.92%
Depreciation & Amortization	$1.842M	$1.800M	$540.0K
YoY Change	98.92%	233.33%	-41.68%
% of Gross Profit		77.35%	4.51%
Operating Expenses	$8.296M	$8.805M	$10.02M
YoY Change	-49.33%	-12.13%	31.43%
Operating Profit	-$11.35M	-$6.478M	$1.953M
YoY Change	123.03%	-431.69%	-153.55%
Interest Expense	-$455.0K	$275.0K	$201.0K
YoY Change	359.6%	36.82%	-160.73%
% of Operating Profit			10.29%
Other Income/Expense, Net	$142.0K	-$33.00K	$0.00
YoY Change
Pretax Income	-$11.67M	-$6.785M	$1.777M
YoY Change	124.8%	-481.82%	-144.67%
Income Tax	-$2.914M	-$1.644M	$809.0K
% Of Pretax Income			45.53%
Net Earnings	-$8.751M	-$5.141M	$968.0K
YoY Change	258.06%	-631.1%	-124.33%
Net Earnings / Revenue	-201.13%	-61.46%	4.0%
Basic Earnings Per Share		-$0.30	$0.06
Diluted Earnings Per Share	-$0.48	-$0.30	$0.06
COMMON SHARES
Basic Shares Outstanding	18.05M shares	16.85M shares	16.01M shares
Diluted Shares Outstanding		17.18M shares	20.25K shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.736M	$3.267M	$26.48M
YoY Change	-72.84%	-87.66%	15.82%
Cash & Equivalents	$1.609M	$702.0K	$22.80M
Short-Term Investments	$3.127M	$2.565M	$3.678M
Other Short-Term Assets	$2.695M	$2.830M	$1.105M
YoY Change	13.91%	156.11%	-40.33%
Inventory	$3.841M	$5.054M	$4.912M
Prepaid Expenses
Receivables	$36.31M	$38.64M	$37.83M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$47.59M	$49.79M	$70.33M
YoY Change	-21.78%	-29.2%	60.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.47M	$13.16M	$6.063M
YoY Change	139.71%	117.1%	-44.57%
Goodwill	$5.231M	$5.231M	$5.709M
YoY Change	-8.37%	-8.37%
Intangibles	$12.33M	$13.02M	$8.889M
YoY Change	45.52%	46.42%
Long-Term Investments
YoY Change
Other Assets	$9.308M	$1.163M	$1.282M
YoY Change	700.34%	-9.28%	-73.52%
Total Long-Term Assets	$44.34M	$41.92M	$27.55M
YoY Change	65.36%	52.14%	-4.09%
TOTAL ASSETS
Total Short-Term Assets	$47.59M	$49.79M	$70.33M
Total Long-Term Assets	$44.34M	$41.92M	$27.55M
Total Assets	$91.93M	$91.71M	$97.88M
YoY Change	4.88%	-6.3%	34.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.383M	$5.467M	$1.545M
YoY Change	58.9%	253.85%	-35.46%
Accrued Expenses	$1.291M	$1.300M	$328.0K
YoY Change	80.81%	296.34%	-94.24%
Deferred Revenue	$2.382M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.840M	$1.840M
YoY Change
Total Short-Term Liabilities	$20.86M	$16.41M	$16.69M
YoY Change	29.75%	-1.72%	68.07%
LONG-TERM LIABILITIES
Long-Term Debt	$7.016M	$4.440M	$7.999M
YoY Change	192.33%	-44.49%	-20.61%
Other Long-Term Liabilities	$14.67M	$14.44M	$5.264M
YoY Change	175.87%	174.32%	20.79%
Total Long-Term Liabilities	$21.69M	$18.88M	$13.26M
YoY Change	173.07%	42.32%	-8.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.86M	$16.41M	$16.69M
Total Long-Term Liabilities	$21.69M	$18.88M	$13.26M
Total Liabilities	$42.54M	$35.28M	$29.96M
YoY Change	77.14%	17.78%	22.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.029M	$3.722M	$14.20M
YoY Change	-142.79%	-73.79%
Common Stock	$18.00K	$18.00K	$17.00K
YoY Change	12.5%	5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$54.14M
YoY Change
Treasury Stock Shares			17.71M shares
Shareholders Equity	$49.38M	$56.43M	$67.92M
YoY Change
Total Liabilities & Shareholders Equity	$91.93M	$91.71M	$97.88M
YoY Change	4.88%	-6.3%	34.76%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$8.751M	-$5.141M	$968.0K
YoY Change	258.06%	-631.1%	-124.33%
Depreciation, Depletion And Amortization	$1.842M	$1.800M	$540.0K
YoY Change	98.92%	233.33%	-41.68%
Cash From Operating Activities	-$213.0K	-$4.660M	$2.632M
YoY Change	-126.26%	-277.05%	-147.66%
INVESTING ACTIVITIES
Capital Expenditures	$1.310M	$670.0K	-$554.0K
YoY Change	-17.92%	-220.94%	2538.1%
Acquisitions
YoY Change
Other Investing Activities	$46.00K	$1.000M	-$116.0K
YoY Change	-101.35%	-962.07%	-96.54%
Cash From Investing Activities	-$1.264M	$330.0K	-$670.0K
YoY Change	-74.74%	-149.25%	-80.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.924M	1.200M	-3.122M
YoY Change	-130.79%	-138.44%
NET CHANGE
Cash From Operating Activities	-213.0K	-4.660M	2.632M
Cash From Investing Activities	-1.264M	330.0K	-670.0K
Cash From Financing Activities	2.924M	1.200M	-3.122M
Net Change In Cash	1.447M	-3.130M	-1.160M
YoY Change	-110.57%	169.83%	-86.96%
FREE CASH FLOW
Cash From Operating Activities	-$213.0K	-$4.660M	$2.632M
Capital Expenditures	$1.310M	$670.0K	-$554.0K
Free Cash Flow	-$1.523M	-$5.330M	$3.186M
YoY Change	94.01%	-267.29%	-157.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40885000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	100824000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8328000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38642000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37054000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	5054000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3976000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2831000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2366000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13015000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8475000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	5231000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5709000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3832000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1163000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1163000	usd
CY2023Q3	us-gaap	Assets Assets	91710000	usd
CY2023Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	113000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	99000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1840000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	947000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	301000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2447000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2499000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	3309000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4190000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2042000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2072000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16406000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16075000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	796000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1059000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	224000	usd
CY2023Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	2000000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4436000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4345000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4259000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7942000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	35282000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24017000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18045029	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16210776	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	18000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	118132000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	109138000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3722000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11753000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	18940967	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	18126970	shares
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	64000000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	58033000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1444000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	757000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	56428000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	63631000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	91710000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87648000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8365000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24200000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6038000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12227000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21590000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	41453000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	11973000	usd
	us-gaap	Professional Fees ProfessionalFees	1932000	usd
	us-gaap	Professional Fees ProfessionalFees	8869000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8245000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7512000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26480000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	428000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	110000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1144000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	174000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	10020000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10261000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	28685000	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	1000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	25000	usd
	us-gaap	Interest Income Other InterestIncomeOther	39000	usd
	us-gaap	Interest Income Other InterestIncomeOther	123000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	275000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	201000	usd
	us-gaap	Interest Expense InterestExpense	781000	usd
	us-gaap	Interest Expense InterestExpense	635000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-76000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-33000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6785000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1777000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1644000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2032000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-51000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7173000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	917000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2565000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	49794000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	60833000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13163000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7288000	usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	832000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	121000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4680000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4059000	usd
CY2022Q4	us-gaap	Assets Assets	87648000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5467000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5905000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	241000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1009000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	18876000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Gross Profit GrossProfit	2327000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21643000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	8805000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	809000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5141000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	968000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5141000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17175000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15898000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17175000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20248000	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	59257000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2400000	usd
CY2023Q3	prph	Issuance Of Common Stock Upon Exercise Of Warrant Amount IssuanceOfCommonStockUponExerciseOfWarrantAmount	1200000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2032000	usd
CY2023Q3	prph	Prepaid Share Based Compensation Expense PrepaidShareBasedCompensationExpense	1138000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	744000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5141000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	56428000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	68157000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-3072000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-51000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1969000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	968000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	67921000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	63631000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	588000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2400000	usd
	prph	Issuance Of Common Stock Upon Exercise Of Warrant Amount IssuanceOfCommonStockUponExerciseOfWarrantAmount	1200000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	398000	usd
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-5379000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2201000	usd
	prph	Prepaid Share Based Compensation Expense PrepaidShareBasedCompensationExpense	1138000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3998000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8031000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	56428000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	58628000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	600000	usd
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-4531000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1199000	usd
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9351000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-112000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2979000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	67921000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8031000	usd
	us-gaap	Net Income Loss NetIncomeLoss	20907000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	3000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-192000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4435000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3792000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	97000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	325000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	254000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-14000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2860000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2979000	usd
	prph	Change In Fair Value Of Investment Securities ChangeInFairValueOfInvestmentSecurities	0	usd
	prph	Change In Fair Value Of Investment Securities ChangeInFairValueOfInvestmentSecurities	-76000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1444000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	718000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2528000	usd
	prph	Inventory Valuation Reserve InventoryValuationReserve	0	usd
	prph	Inventory Valuation Reserve InventoryValuationReserve	-179000	usd
	prph	Noncash Interest Income On Secured Promissory Note Receivable NoncashInterestIncomeOnSecuredPromissoryNoteReceivable	-74000	usd
	prph	Noncash Interest Income On Secured Promissory Note Receivable NoncashInterestIncomeOnSecuredPromissoryNoteReceivable	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2380000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2652000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1078000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	133000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	938000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-643000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4350000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1339000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	674000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-438000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5483000	usd
	prph	Increase Decrease In Accrued Diagnostic Services IncreaseDecreaseInAccruedDiagnosticServices	-768000	usd
	prph	Increase Decrease In Accrued Diagnostic Services IncreaseDecreaseInAccruedDiagnosticServices	-1616000	usd
	prph	Increase Decrease In Accrued Advertising And Other Allowances IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances	14000	usd
	prph	Increase Decrease In Accrued Advertising And Other Allowances IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances	-25000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-315000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	946000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-307000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-139000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-223000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-881000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7029000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-30000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11135000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27740000	usd
	us-gaap	Escrow Deposits Related To Property Sales EscrowDepositsRelatedToPropertySales	478000	usd
	us-gaap	Escrow Deposits Related To Property Sales EscrowDepositsRelatedToPropertySales	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2904000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3819000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1003000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4168000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3817000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5800000	usd
	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	452000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1845000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2323000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2926000	usd
	prph	Proceeds From Issuance Of Common Stock And Warrants From Private Offering ProceedsFromIssuanceOfCommonStockAndWarrantsFromPrivateOffering	7600000	usd
	prph	Proceeds From Issuance Of Common Stock And Warrants From Private Offering ProceedsFromIssuanceOfCommonStockAndWarrantsFromPrivateOffering	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1200000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	prph	Repurchase Of Common Stock For Payment Of Statutory Taxes Due On Cashless Exercise Of Stock Option RepurchaseOfCommonStockForPaymentOfStatutoryTaxesDueOnCashlessExerciseOfStockOption	5379000	usd
	prph	Repurchase Of Common Stock For Payment Of Statutory Taxes Due On Cashless Exercise Of Stock Option RepurchaseOfCommonStockForPaymentOfStatutoryTaxesDueOnCashlessExerciseOfStockOption	4530000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	588000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1200000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	9351000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2833000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16525000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8407000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14141000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9109000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8658000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	702000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22799000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	usd
	us-gaap	Interest Paid Net InterestPaidNet	740000	usd
	us-gaap	Interest Paid Net InterestPaidNet	631000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1138000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
	prph	Issuance Of Common Shares For Debt Conversion IssuanceOfCommonSharesForDebtConversion	2400000	usd
	prph	Issuance Of Common Shares For Debt Conversion IssuanceOfCommonSharesForDebtConversion	600000	usd
	prph	Net Unrealized Loss Gain Investments In Marketable Debt Securities NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities	2083000	usd
	prph	Net Unrealized Loss Gain Investments In Marketable Debt Securities NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities	-113000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6201000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	prph	Issuance Of Warrants With Unsecured Promissory Note IssuanceOfWarrantsWithUnsecuredPromissoryNote	398000	usd
	prph	Issuance Of Warrants With Unsecured Promissory Note IssuanceOfWarrantsWithUnsecuredPromissoryNote	0	usd
	us-gaap	Stock Issued1 StockIssued1	1000000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q3	prph	Number Of Inhibitors NumberOfInhibitors	2	inhibitor
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and the accompanying notes thereto, in conformity with GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration of diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, allowances, slow moving and/or dated inventory and associated provisions, the potential impairment of long-lived assets, stock based compensation valuations, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the condensed consolidated financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div>
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	2565000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	8328000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	500000	usd
CY2022Q4	prph	Asset Acquisition Consideration Transferred Liability Payoff AssetAcquisitionConsiderationTransferredLiabilityPayoff	1600000	usd
CY2022Q4	prph	Asset Acquisition Consideration Transferred Promissory Note Payoff AssetAcquisitionConsiderationTransferredPromissoryNotePayoff	400000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2022Q4	prph	Asset Acquisition Shares Issued And Issuable Value Per Share AssetAcquisitionSharesIssuedAndIssuableValuePerShare	10.00
CY2022Q4	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	4600000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	500000	usd
CY2022Q4	prph	Asset Acquisition Consideration Transferred Promissory Note Payoff AssetAcquisitionConsiderationTransferredPromissoryNotePayoff	400000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	2000000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	2000000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	2000000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	2000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y
CY2022Q4	prph	Asset Acquisition Transaction Costs AssetAcquisitionTransactionCosts	200000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19101000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12297000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6086000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3822000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13015000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	682000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2583000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2583000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2251000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1731000	usd
CY2023Q3	prph	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	3185000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13015000	usd
CY2022Q1	us-gaap	Cash Cash	1441000	usd
CY2022Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	1400000	usd
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	41000	usd
CY2022Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	5.75
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1150000	usd
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	2591000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4600000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2022Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4700000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	6000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P9M
CY2023Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P9M
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	6000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P9M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1125000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4100000	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	744369	shares
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5400000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	603881	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	10.00
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	300000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P1Y
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1200000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.00
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2900000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000	usd
	prph	Share Based Payment Arrangement Expense Remaining ShareBasedPaymentArrangementExpenseRemaining	6600000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2788
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0211
CY2021Q2	prph	Manufacturing Agreement Renewal Options ManufacturingAgreementRenewalOptions	4	period
CY2021Q2	prph	Manufacturing Agreement Renewal Period ManufacturingAgreementRenewalPeriod	P1Y
CY2021Q2	prph	Agreement Term AgreementTerm	P90D
CY2022Q4	prph	Manufacturing Agreement Renewal Period ManufacturingAgreementRenewalPeriod	P1Y
CY2022Q3	prph	License Agreement Term LicenseAgreementTerm	P10D
CY2023Q1	prph	Number Of Sites NumberOfSites	12	site
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5300000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4600000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4100000	usd
CY2023Q2	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P5Y
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1500000	usd
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.080
CY2023Q3	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P4Y
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	5100000	usd
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.074
CY2023Q3	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P3Y
CY2023Q3	prph	Finance Lease Cost FinanceLeaseCost	440000	usd
	prph	Finance Lease Cost FinanceLeaseCost	510000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	215000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	204000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	717000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	612000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	215000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	204000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	717000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	612000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	122000	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	142000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	318000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	368000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
CY2023Q3	prph	Finance Lease Cost FinanceLeaseCost	440000	usd
CY2022Q3	prph	Finance Lease Cost FinanceLeaseCost	0	usd
	prph	Finance Lease Cost FinanceLeaseCost	510000	usd
	prph	Finance Lease Cost FinanceLeaseCost	0	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	606000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	580000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.08
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6201000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	368000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	232000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	460000	usd
CY2023Q3	prph	Lease Liability To Be Paid Remainder Of Fiscal Year LeaseLiabilityToBePaidRemainderOfFiscalYear	692000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	953000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1840000	usd
CY2023Q3	prph	Lease Liability To Be Paid Year One LeaseLiabilityToBePaidYearOne	2793000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	977000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1840000	usd
CY2023Q3	prph	Lease Liability To Be Paid Year Two LeaseLiabilityToBePaidYearTwo	2817000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	941000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1840000	usd
CY2023Q3	prph	Lease Liability To Be Paid Year Three LeaseLiabilityToBePaidYearThree	2781000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	955000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1188000	usd
CY2023Q3	prph	Lease Liability To Be Paid Year Four LeaseLiabilityToBePaidYearFour	2143000	usd
CY2023Q3	prph	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3649000	usd
CY2023Q3	prph	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	122000	usd
CY2023Q3	prph	Lease Liability Payments Due After Year Four LeaseLiabilityPaymentsDueAfterYearFour	3771000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7707000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7290000	usd
CY2023Q3	prph	Lease Liability To Be Paid LeaseLiabilityToBePaid	14997000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2415000	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1014000	usd
CY2023Q3	prph	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	3429000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5292000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	6276000	usd
CY2023Q3	prph	Lease Liability LeaseLiability	11568000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8365000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24200000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6038000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12227000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2571000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1019000	usd
CY2023Q3	prph	Operating And Other Expenses OperatingAndOtherExpenses	6541000	usd
CY2022Q3	prph	Operating And Other Expenses OperatingAndOtherExpenses	9176000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6785000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1777000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1644000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	809000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5141000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	968000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5141000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	968000	usd
CY2023Q3	us-gaap	Assets Assets	91710000	usd
CY2022Q4	us-gaap	Assets Assets	87648000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5141000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	968000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8031000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20907000	usd
CY2023Q3	prph	Interest On Unsecured Convertible Promissory Note InterestOnUnsecuredConvertiblePromissoryNote	0	usd
CY2022Q3	prph	Interest On Unsecured Convertible Promissory Note InterestOnUnsecuredConvertiblePromissoryNote	201000	usd
	prph	Interest On Unsecured Convertible Promissory Note InterestOnUnsecuredConvertiblePromissoryNote	0	usd
	prph	Interest On Unsecured Convertible Promissory Note InterestOnUnsecuredConvertiblePromissoryNote	635000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5141000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1169000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8031000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	21542000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17175000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15898000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16924000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15712000	shares
CY2023Q3	prph	Diluted Shares Stock Options DilutedSharesStockOptions	0	shares
CY2022Q3	prph	Diluted Shares Stock Options DilutedSharesStockOptions	2453000	shares
	prph	Diluted Shares Stock Options DilutedSharesStockOptions	0	shares
	prph	Diluted Shares Stock Options DilutedSharesStockOptions	1925000	shares
CY2023Q3	prph	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants	0	shares
CY2022Q3	prph	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants	1097000	shares
	prph	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants	0	shares
	prph	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants	1067000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	800000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	800000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17175000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20248000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16924000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19504000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4120000	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	825000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4120000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1065000	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000868278-23-000017-index-headers.html	Edgar Link	pending
0000868278-23-000017-index.html	Edgar Link	pending
0000868278-23-000017.txt	Edgar Link	pending
0000868278-23-000017-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prph-20230930.htm	Edgar Link	pending
prph-20230930.xsd	Edgar Link	pending
prph-20230930xexx311.htm	Edgar Link	pending
prph-20230930xexx312.htm	Edgar Link	pending
prph-20230930xexx321.htm	Edgar Link	pending
prph-20230930xexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
prph-20230930_cal.xml	Edgar Link	unprocessable
prph-20230930_def.xml	Edgar Link	unprocessable
prph-20230930_lab.xml	Edgar Link	unprocessable
prph-20230930_pre.xml	Edgar Link	unprocessable
prph-20230930_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRPH
ProPhase Labs, Inc. Stock $prph

2023 Q4 Form 10-Q Financial Statement

#000086827823000017 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPH ProPhase Labs, Inc. Stock $prph

2023 Q4 Form 10-Q Financial Statement

#000086827823000017 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPH
ProPhase Labs, Inc. Stock $prph